Search

everythinglearnresearchcommunity

for

Search:↓

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Folliculitis decalvans mainly affects middle-aged African American men and is treated with antibiotics.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

The document is a detailed medical reference on skin and genetic disorders.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Aging can lead to poorer scalp and hair health, including less hair and more scalp diseases, which should be managed to help older people feel better.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

Old people's nails often have problems due to body changes, more diseases, and self-care difficulties, affecting their movement and hand use.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The document reviews key historical figures and discoveries in dermatology.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

The document lists various dermatology topics, treatments, and diagnostic methods.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

The conclusion of the case is not provided in the summary.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

A man's scalp infection, mistaken for bacterial, was actually a rare fungal infection treated successfully with antifungal medication.

Breast cancer skin metastases are rare, look different, and can be confused with other skin issues, so a biopsy is needed for accurate diagnosis.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.